Systematic implantation of dedifferentiated fat cells ameliorated monoclonal antibody 1-22-3-induced glomerulonephritis by immunosuppression with increases in TNF-stimulated gene 6.

Abstract

INTRODUCTION:

Implantation of mesenchymal stem cells (MSCs) has recently been reported to repair tissue injuries through anti-inflammatory and immunosuppressive effects. We established dedifferentiated fat (DFAT) cells that show identical characteristics to MSCs.

METHODS:

We examined the effects of 10(6) of DFAT cells infused through renal artery or tail vein on monoclonal antibody (mAb) 1-22-3-induced glomerulonephritis (as an immunological type of renal injury) and adriamycin-induced nephropathy (as a non-immunological type of renal injury) in rats. The mAb 1-22-3-injected rats were also implanted with 10(6) of DFAT cells transfected with TSG-6 siRNA through tail vein.

RESULTS:

Although DFAT cells transfused into blood circulation through the tail vein were trapped mainly in lungs without reaching the kidneys, implantation of DFAT cells reduced proteinuria and improved glomerulosclerosis and interstitial fibrosis. Implantation of DFAT cells through the tail vein significantly decreased expression of kidney injury molecule-1, collagen IV and fibronectin mRNAs, whereas nephrin mRNA expression was increased. Implantation of DFAT cells did not improve adriamycin-induced nephropathy, but significantly decreased the glomerular influx of macrophages, common leukocytes and pan T cells. However, the glomerular influx of helper T cells, was increased. Implantation of DFAT cells decreased expression of interleukin (IL)-6 and IL-12β mRNAs and increased expression of TNF-stimulated gene (TSG)-6 mRNA in renal cortex from mAb 1-22-3-injected rats. The basal level of TSG-6 protein was significantly higher in DFAT cells than in fibroblasts. Expression of TSG-6 mRNA in MCs cocultured with DFAT cells was significantly higher than in mesangial cells or DFAT cells alone. Systematic implantation of DFAT cells with TSG-6 siRNA through tail vein did not improve proteinuria, renal dysfunction and renal degeneration in the mAb 1-22-3-injected rats.

CONCLUSION:

Systematic implantation of DFAT cells effectively ameliorated mAb 1-22-3-induced glomerulonephritis through immunosuppressive effects accompanied by the suppression of macrophage infiltration and expression of IL-6, IL-10 and IL-12β, and increased production of serum and renal TSG-6 that improved the mAb 1-22-3-induced renal degeneration by the immunosuppressive effects of TSG-6. Thus DFAT cells will be suitable cell source for the treatment of immunological progressive renal diseases.

• Authors: Takashi Maruyama, Noboru Fukuda, Taro Matsumoto, Koichiro Kano, Morito Endo, Minako Kazama, Tomohiko Kazama, Jin Ikeda, Hiroyuki Matsuda, Takahiro Ueno, Masanori Abe, Kazuyoshi Okada, Masayoshi Soma, Koichi Matsumoto, Hiroshi Kawachi
• Journal: Stem cell research & therapy (Stem Cell Res Ther) Vol. 6 Pg. 80 (Apr 16 2015) ISSN: 1757-6512 [Electronic] England
• PMID: 25889917 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antibodies, Monoclonal
• Cell Adhesion Molecules
• Cytokines
• Tnfaip6 protein, rat

Topics

• Adipose Tissue (cytology)
• Animals
• Antibodies, Monoclonal (administration & dosage)
• Cell Adhesion Molecules (antagonists & inhibitors, genetics, metabolism)
• Cell Dedifferentiation
• Coculture Techniques
• Cytokines (genetics, metabolism)
• Glomerulonephritis (etiology, therapy)
• Immunosuppression Therapy
• Kidney Cortex (metabolism, pathology)
• Macrophages (cytology, immunology)
• Male
• Mice
• Mice, Inbred BALB C
• Nephritis (chemically induced, therapy)
• Proteinuria (metabolism, pathology)
• Rats
• Rats, Inbred SHR
• Rats, Wistar
• Stem Cell Transplantation
• Stem Cells (cytology, metabolism)